Stock Market News Live: Nifty At 25,100, Sensex Up 200 Points; Nifty Midcap Outperforms The Benchmarks
The GIFT Nifty was trading 0.18% higher above 25,100 early Thursday. The futures contract based on the benchmark Nifty 50 rose to 25,137.5 as of 6:34 a.m.
Stock Market Live: Signature Global In Focus
Signatureglobal (India) Ltd., has approved a major fundraising initiative. The company's exchange filing confirmed the decision.
They will issue 87,500 Non-Convertible Debentures (NCDs). The total value of these debentures is Rs 875 crore. This issuance will be executed on a private placement basis.
Stock Market Live: Nifty 50 Check
The top gainers in the Nifty 50 pack was JSW Steel, HCL Tech as of 2:07 p.m. Names like Tata Steel, SBI Life, Indigo also marked notable gains.
The counters trading in red were Tata Motors, Axis Bank and Maruti Suzuki.
Stock Market Live: Nifty Midcap 100 Outperforms The Benchmark
The Nifty Midcap 100 is outperforming the benchmarks as of 1:15 p.m. The gains of the Midcap index stand at 0.73%, compared to the Nifty 50, trading 0.34% higher and the Sensex that is up 200 points.
Stock Market Live: Citi On Pharma
Trump administration is not actively discussing imposing section 232 tariffs against generic pharmaceuticals
Though the move isn’t final, it is largely in-line with our stance and may help lift the tariffs-related overhang
Remain cautious on the US generics due to multiple reasons
Among the US generic heavy names, prefer Lupin on valuations
Stock Market Live: Jefferies On Pharma
Recent news provides relief to export pharma companies
Dr Reddy's, Zydus, Lupin, Cipla and Sun which derive 25-50% of their revenue from the US
Amongst generics, preferred pick is Lupin
Companies like Dr Reddy's, Zydus and Cipla may have near term earnings headwinds
